Anne Olson - 01 Jan 2023 Form 4 Insider Report for CENTERSPACE (CSR)

Role
COO, Gen Counsel and Secretary
Signature
Anne Olson
Issuer symbol
CSR
Transactions as of
01 Jan 2023
Net transactions value
+$636,217
Form type
4
Filing time
04 Jan 2023, 14:01:49 UTC
Previous filing
04 May 2022
Next filing
15 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSR Common Shares of Beneficial Interest Options Exercise $0 +540 +3.8% $0.000000 14,633 01 Jan 2023 Direct
transaction CSR Common Shares of Beneficial Interest Options Exercise $0 +373 +2.5% $0.000000 15,006 01 Jan 2023 Direct
transaction CSR Common Shares of Beneficial Interest Tax liability $26,402 -450 -3% $58.67 14,556 01 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CSR Restricted Stock Units Award $0 +3,022 $0.000000 3,022 01 Jan 2023 Common Shares of Beneficial Interest 3,022 $0.000000 Direct F2
transaction CSR Stock Options (Right to Buy) Award $662,619 +11,294 $58.67 11,294 01 Jan 2023 Common Shares of Beneficial Interest 11,294 $58.67 Direct F3
transaction CSR Restricted Stock Units Options Exercise $0 -540 -50% $0.000000 540 01 Jan 2023 Common Shares of Beneficial Interest 540 $0.000000 Direct
transaction CSR Restricted Stock Units Options Exercise $0 -373 -33% $0.000000 748 01 Jan 2023 Common Shares of Beneficial Interest 373 $0.000000 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for payment of taxes in connection with the vesting of restricted stock units.
F2 Represents a time-based contingent right to receive 3,022 common shares of beneficial interest of Centerspace vesting over three years in one-third increments on each anniversary of the grant date: January 1, 2024, 2025 and 2026.
F3 Represents the right to purchase 11,294 common shares of beneficial interest of Centerspace, vesting over four years in one-fourth increments on each anniversary of the grant date: January 1, 2024, 2025, 2026 and 2027.